Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment

BACKGROUND: Hepatitis B surface antigen (HBsAg) loss/seroconversion is considered to be the ideal endpoint of antiviral therapy and the ultimate treatment goal in chronic hepatitis B (CHB). This study aimed to assess the patterns of HBsAg kinetics in CHB patients who achieved HBsAg loss during the t...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Chin Med J (Engl)
Hoofdauteurs: Li, Ming-Hui, Zhang, Lu, Qu, Xiao-Jing, Lu, Yao, Shen, Ge, Wu, Shu-Ling, Chang, Min, Liu, Ru-Yu, Hu, Lei-Ping, Li, Zhen-Zhen, Hua, Wen-Hao, Song, Shu-Jing, Xie, Yao
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Medknow Publications & Media Pvt Ltd 2017
Onderwerpen:
Original Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5339929/
https://ncbi.nlm.nih.gov/pubmed/28229987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0366-6999.200554
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items